The global healthcare nanotechnology market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for nanomedicine and nano medical devices in the healthcare sector. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is also driving the growth of this market.
Nanomedicine is one of the major segments in this market and it accounted for more than 50% share in 2018. This segment includes products such as nanoparticles, liposomes, dendrimers, quantum dots, and others that are used for diagnosis or treatment purposes. Nano medical devices accounted for more than 30% share in 2018 due to their wide range of applications including drug delivery systems (e.g., inhalers), diagnostic tools (e.g., MRI), surgical instruments (e.g., scalpels), implants (e.g., pacemakers) among others which are used by physicians across various specialties such as cardiology or oncology among others.
Some Of The Growth Factors Of This Market:
- The healthcare nanotechnology market is driven by the increasing demand for minimally invasive procedures, rising prevalence of chronic diseases, and growing geriatric population.
- Healthcare nanotechnology products are used in various applications such as drug delivery, diagnostics, and therapeutics.
- The healthcare nanotechnology market is segmented into product type (drug delivery systems, diagnostic tools & devices), application (diagnostic tools & devices), end user (hospitals & clinics).
Industry Growth Insights published a new data on “Healthcare Nanotechnology Market”. The research report is titled “Healthcare Nanotechnology Market research by Types (Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog), By Applications (Anticancer, CNS Product, Anti-infective, Others), By Players/Companies Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International, Healthcare Nanotechnolog”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Healthcare Nanotechnology Market Research Report
By Type
Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog
By Application
Anticancer, CNS Product, Anti-infective, Others
By Companies
Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International, Healthcare Nanotechnolog
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Healthcare Nanotechnology Market Report Segments:
The global Healthcare Nanotechnology market is segmented on the basis of:
Types
Nanomedicine, Nano Medical Devices, Nano Diagnosis, Others, Healthcare Nanotechnolog
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anticancer, CNS Product, Anti-infective, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- Teva Pharmaceuticals
- Abbott
- UCB
- Roche
- Celgene
- Sanofi
- Merck & Co
- Biogen
- Stryker
- Gilead Sciences
- Pfizer
- 3M Company
- Johnson & Johnson
- Smith & Nephew
- Leadiant Biosciences
- Kyowa Hakko Kirin
- Takeda
- Ipsen
- Endo International
- Healthcare Nanotechnolog
Highlights of The Healthcare Nanotechnology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nanomedicine
- Nano Medical Devices
- Nano Diagnosis
- Others
- Healthcare Nanotechnolog
- By Application:
- Anticancer
- CNS Product
- Anti-infective
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Healthcare Nanotechnology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Healthcare nanotechnology is the application of nanotechnology to healthcare. It refers to the use of nanoparticles and other small-scale technologies in healthcare products and services, with an aim of improving patient health. Healthcare nanotechnology can improve delivery of drugs and other treatments, help diagnose diseases more accurately, or improve surgical procedures.
Some of the major companies in the healthcare nanotechnology market are Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International, Healthcare Nanotechnolog.
The healthcare nanotechnology market is expected to register a CAGR of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare Nanotechnology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Healthcare Nanotechnology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Healthcare Nanotechnology Market - Supply Chain
4.5. Global Healthcare Nanotechnology Market Forecast
4.5.1. Healthcare Nanotechnology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Healthcare Nanotechnology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Healthcare Nanotechnology Market Absolute $ Opportunity
5. Global Healthcare Nanotechnology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Healthcare Nanotechnology Market Size and Volume Forecast by Type
5.3.1. Nanomedicine
5.3.2. Nano Medical Devices
5.3.3. Nano Diagnosis
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Healthcare Nanotechnology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Healthcare Nanotechnology Market Size and Volume Forecast by Application
6.3.1. Anticancer
6.3.2. CNS Product
6.3.3. Anti-infective
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Healthcare Nanotechnology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Healthcare Nanotechnology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Healthcare Nanotechnology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Healthcare Nanotechnology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Healthcare Nanotechnology Demand Share Forecast, 2019-2029
9. North America Healthcare Nanotechnology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Healthcare Nanotechnology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Healthcare Nanotechnology Market Size and Volume Forecast by Application
9.4.1. Anticancer
9.4.2. CNS Product
9.4.3. Anti-infective
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Healthcare Nanotechnology Market Size and Volume Forecast by Type
9.7.1. Nanomedicine
9.7.2. Nano Medical Devices
9.7.3. Nano Diagnosis
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Healthcare Nanotechnology Demand Share Forecast, 2019-2029
10. Latin America Healthcare Nanotechnology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Healthcare Nanotechnology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Healthcare Nanotechnology Market Size and Volume Forecast by Application
10.4.1. Anticancer
10.4.2. CNS Product
10.4.3. Anti-infective
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Healthcare Nanotechnology Market Size and Volume Forecast by Type
10.7.1. Nanomedicine
10.7.2. Nano Medical Devices
10.7.3. Nano Diagnosis
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Healthcare Nanotechnology Demand Share Forecast, 2019-2029
11. Europe Healthcare Nanotechnology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Healthcare Nanotechnology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Healthcare Nanotechnology Market Size and Volume Forecast by Application
11.4.1. Anticancer
11.4.2. CNS Product
11.4.3. Anti-infective
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Healthcare Nanotechnology Market Size and Volume Forecast by Type
11.7.1. Nanomedicine
11.7.2. Nano Medical Devices
11.7.3. Nano Diagnosis
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Healthcare Nanotechnology Demand Share, 2019-2029
12. Asia Pacific Healthcare Nanotechnology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Healthcare Nanotechnology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Healthcare Nanotechnology Market Size and Volume Forecast by Application
12.4.1. Anticancer
12.4.2. CNS Product
12.4.3. Anti-infective
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Healthcare Nanotechnology Market Size and Volume Forecast by Type
12.7.1. Nanomedicine
12.7.2. Nano Medical Devices
12.7.3. Nano Diagnosis
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Healthcare Nanotechnology Demand Share, 2019-2029
13. Middle East & Africa Healthcare Nanotechnology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Healthcare Nanotechnology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Healthcare Nanotechnology Market Size and Volume Forecast by Application
13.4.1. Anticancer
13.4.2. CNS Product
13.4.3. Anti-infective
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Healthcare Nanotechnology Market Size and Volume Forecast by Type
13.7.1. Nanomedicine
13.7.2. Nano Medical Devices
13.7.3. Nano Diagnosis
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Healthcare Nanotechnology Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Healthcare Nanotechnology Market: Market Share Analysis
14.2. Healthcare Nanotechnology Distributors and Customers
14.3. Healthcare Nanotechnology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amgen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. UCB
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Celgene
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merck & Co
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biogen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Stryker
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Gilead Sciences
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Pfizer
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. 3M Company
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Johnson & Johnson
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Smith & Nephew
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Leadiant Biosciences
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Kyowa Hakko Kirin
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Shire
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Ipsen
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Endo International
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
